DrugPatentWatch Database Preview
TIROSINT-SOL Drug Profile
Email this page to a colleague
See Plans and PricingWhich patents cover Tirosint-sol, and when can generic versions of Tirosint-sol launch?
Tirosint-sol is a drug marketed by Institut Biochimique and is included in one NDA.
The generic ingredient in TIROSINT-SOL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
US ANDA Litigation and Generic Entry Outlook for Tirosint-sol
A generic version of TIROSINT-SOL was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for TIROSINT-SOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 52 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,601 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TIROSINT-SOL |
| DailyMed Link: | TIROSINT-SOL at DailyMed |
Recent Clinical Trials for TIROSINT-SOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| IBSA Institut Biochimique SA | Phase 4 |
| Meyer Children's Hospital | Phase 4 |
| University of Colorado, Denver | N/A |
Pharmacology for TIROSINT-SOL
| Drug Class | l-Thyroxine |
Synonyms for TIROSINT-SOL
| (-)-Thyroxine Sodium |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt |
| (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt |
| 054I36CPMN |
| 137-53-1 |
| 25416-65-3 |
| 3,3?,5,5?-Tetraiodo-L-thyronine sodium salt |
| 3,3',5,5'-Tetraiodo-L-thyronine Sodium |
| 3,3',5,5'-Tetraiodo-L-thyronine sodium salt |
| 3,3',5,5'-Tetraiodo-L-thyronine, sodium salt |
| 50809-32-0 |
| 55-03-8 |
| 6260AF |
| 67809-22-7 |
| A830452 |
| AC-10210 |
| AC-919 |
| AK-46618 |
| AKOS015918420 |
| AKOS024284731 |
| API0007805 |
| BBC/815 |
| BC204258 |
| Berlthyrox |
| C08212 |
| C15H10I4NO4.Na |
| CHEBI:6446 |
| CT-452 |
| CTK4J3191 |
| D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt |
| D11113 |
| Dathroid |
| EBD2201200 |
| Eferox |
| EINECS 200-221-4 |
| eltroxin |
| Epitope ID:136776 |
| Euthyrox |
| FT-0628030 |
| FT-0658959 |
| Henning Sodium |
| I14-8105 |
| J-524276 |
| KS-00000F9R |
| L-T4 Sodium |
| L-Thyroxin Sodium |
| l-Thyroxine monosodium salt |
| L-Thyroxine sodium |
| L-Thyroxine sodium salt |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI) |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodiumsalt |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1) |
| Laevoxin |
| Letter |
| Levaxin |
| Leventa |
| Levo-T |
| Levolet |
| Levoroxine |
| levothroid |
| Levothyrox |
| Levothyroxin-natrium |
| Levothyroxine sodique |
| Levothyroxine sodique [INN-French] |
| Levothyroxine sodium |
| Levothyroxine Sodium (anhydrous) |
| Levothyroxine sodium (INN) |
| Levothyroxine Sodium [USAN:INN] |
| Levothyroxine Sodium [USAN] |
| Levothyroxine sodium anhydrous |
| Levothyroxine sodium tablets |
| Levothyroxinum natricum |
| Levothyroxinum natricum [INN-Latin] |
| levotiroxina de sodio |
| Levotiroxina sodica |
| Levotiroxina sodica [INN-Spanish] |
| Levoxyl |
| LS-153817 |
| LS-153822 |
| MolPort-002-511-861 |
| Monosodium L-thyroxine |
| Novothyrox |
| NSC 259940 |
| NSC 36397-Sodium |
| O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine Sodium |
| Oroxine |
| RL03895 |
| RL04067 |
| Ro-thyroxine |
| Roxstan |
| SCHEMBL34102 |
| sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate |
| sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate |
| Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate |
| sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine |
| Sodium l-thyroxin |
| Sodium L-thyroxine |
| Sodium levothyroxine |
| Sodium thyroxin |
| Sodium thyroxinate |
| Sodium thyroxine |
| Sodium-L-thyroxine |
| Soloxine |
| ST078859 |
| synthroid |
| Synthroid sodium |
| T4 Sodium |
| Tetroid |
| Thevier |
| Thyradin |
| Thyradin S |
| Thyrax Sodium |
| Thyreoideum Sodium |
| Thyro-Tabs |
| THYROID |
| Thyronamin |
| Thyrosit |
| Thyroxevan |
| Thyroxin sodium |
| Thyroxinal Sodium |
| Thyroxine sodique |
| Thyroxine sodium |
| Thyroxine sodium salt |
| Thyroxine, monosodium salt, L- |
| Thyroxinique |
| Thyroxinum natricum |
| Tiroidina |
| Tirosint |
| Tyrosint |
| UNII-054I36CPMN |
| Unithroid |
| YDTFRJLNMPSCFM-YDALLXLXSA-M |
| Z2798529463 |
US Patents and Regulatory Information for TIROSINT-SOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-007 | Dec 15, 2016 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Institut Biochimique | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-004 | Dec 15, 2016 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
